| Value | ₹70.00 Cr |
|---|
NSE filing, NSE: HSCL. Summary written from the filing by ALFA Finder's alert engine.
Himadri Speciality Chemical Ltd: key numbers
- Share price
- ₹531.80
- Market cap
- ₹26,833 Cr
- Revenue (annual)
- ₹4,661 Cr
- Net profit (annual)
- ₹751.3 Cr
- P/E (TTM)
- 31.4×Sector 34.1×
- Promoter holding
- 52.49%-0.01% QoQ
- FII holding
- 7.33%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Himadri Speciality Chemical Ltd
All →Himadri Speciality Chemical Other Announcement
Himadri Speciality Chemical's members approved an alteration of its Memorandum of Association and adoption of a new MOA under the Companies Act, 2013. The approval was by special resolution through postal ballot on October 27, 2026.
Himadri Speciality Chemical Annual General Meeting
Himadri Speciality Chemical announced postal ballot results approving a special resolution to alter and adopt a new Memorandum of Association. Remote e-voting concluded 27 October 2026 with the requisite majority.
Himadri Speciality Chemical Earnings Call Transcript: Key Takeaways
Himadri delivered massive 58% revenue growth while maintaining steady margins despite high freight costs.
Himadri Speciality Chemical Investor Presentation: Key Takeaways
Himadri reported strong Q2 FY27 performance with revenue at ₹1,691 Cr and PAT at ₹231 Cr, driven by high-value product transitions and expansion into battery materials.
Himadri Speciality Chemical Results Update
Himadri Speciality Chemical reported consolidated H1FY27 revenue of ₹3,123 Cr and PAT of ₹460 Cr, reflecting growth across its specialty chemicals and battery material portfolios.
Himadri Speciality Chemical Q2 FY27 Results: Net Profit ₹231.3 Cr, Up 31.3% YoY
Himadri Speciality Chemical Ltd reported revenue from operations of ₹1,691 Cr (+57.9% YoY) and net profit of ₹231.3 Cr (+31.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹231.3 Cr · +31.3% YoY
Other capacity expansion announcements
All →Greenply Industries Capacity Expansion: ₹30 Cr Investment
Greenply's board approved further investment of up to INR 30 crore in its wholly owned subsidiary Greenply Sandila Private Limited for plywood capacity expansion. The funds will be paid in one or more tranches by Q4 FY2028.
- Value
- ₹30.00 Cr
- Execution
- Q4 of FY 2028, in one or more tranches
Ethos Capacity Expansion
Ethos has opened a new Ethos Summit boutique at Fort, Mumbai, taking its total to 105 boutiques across India. The filing is an update on a store opening with no monetary value disclosed.
- new boutiques
- 1.0 boutiques
Greenply Industries Capacity Expansion
Greenply's board noted a 15 million sq mtr plywood capacity expansion at subsidiary Greenply Sandila, due by Q4 FY2028. Approximately Rs. 125 crore investment is planned.
- Execution
- By Q4 of FY 2028
- plywood manufacturing capacity
- 15.0 million sq mtr
Senores Pharmaceuticals Capacity Expansion: ₹20 Cr Investment
Senores Pharmaceuticals' subsidiary Apnar Pharma Private Limited plans a 0.7 Bn unit capacity addition by March 2027. The investment is Rs.20.00 Crore, funded by internal accruals and IPO proceeds.
- Value
- ₹20.00 Cr
- Execution
- By end of March 2027
- production capacity
- 0.7 Bn units
Senores Pharmaceuticals Capacity Expansion: ₹18 Cr Investment
Senores Pharmaceuticals plans to add 0.8 Bn units of capacity to its existing 1.2 Bn unit plant by March 2027. The investment is Rs.18.00 Crore, funded by internal accruals and IPO proceeds.
- Value
- ₹18.00 Cr
- Execution
- By end of March 2027
- production capacity
- 0.8 Bn units
EPack Prefab Technologies Capacity Expansion: ₹100 Cr Investment
EPack Prefab plans to add 11,300 MT of PEB and 8,00,000 sq m of PUF capacity. The ₹100 Crore investment will be funded from IPO proceeds.
- Value
- ₹100.0 Cr
- Execution
- Period stated as 28-10-2026 in the filing (date as filed; the period is not otherwise defined)
- PEB structures capacity addition
- 11300.0 MTPA